Fate Therapeutics Q1 2026 Earnings EPS Beat Drives Stock Uptick Amid Continued Pipeline Progress SUNC Q1 2026 Earnings Massive EPS Miss as SunocoCorp Reports Unexpected Loss DBX Q1 2026 Earnings EPS Beat Signals Resilience Despite Revenue Uncertainty EQBK Q1 2026 Earnings EPS Misses Estimates Yet Stock Shows Resilience A10 Networks Q1 2026 Earnings EPS Surprise Drives Positive Market Reaction Crescent Biopharma Inc CBIO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline